Back to Treasuries

Bridge Biotherapeutics Inc

#85 in public 288330.KQ public

Parataxis Korea, Inc., a clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide.

Bitcoin Holdings

Total Bitcoin â‚¿ 200 BTC
% of 21M Supply 0.001%
Current Value $15,329,208
Cost Basis $26,363,984
ROI -41.86%
% of Company 0.0%
mNAV 1186.11x
Market Cap $36,442,669,056
Enterprise Value $39,376,749,056
Latest Purchase Feb 06, 2026
Avg. cost / BTC $131,820

Bridge Biotherapeutics Inc Stock Priced in BTC

0.005783 BTC

Bridge Biotherapeutics Inc Bitcoin Holdings Over Time

â‚¿ 200 BTC

Bitcoin Acquisitions History

Type BTC Change Holdings Transaction Value Date
Buy +0 BTC 0 BTC $0 —
Buy +0 BTC 0 BTC $0 —
Buy +0 BTC 0 BTC $0 —
Buy +0 BTC 0 BTC $0 —
Buy +0 BTC 0 BTC $0 —

Get instant access to full data

Register for free

Financial Highlights

Revenue (TTM) $9,000,000
Profit Margin 0%
Operating Margin -168375.6%
ROE -90.37%
ROA -18.16%
Current Volume 0
Avg Volume (30d) 1,126,485
Volume vs Avg 0.0x

Bridge Biotherapeutics Inc Stock Price vs Bitcoin

$416.00 / $76,646

Company Overview

Parataxis Korea, Inc., a clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide. Its products in pipeline includes BBT-401, a Pellino-1 inhibitor, which is in Phase I clinical trial for the treatment of ulcerative colitis; and BBT-877, an autotaxin inhibitor that is in Phase I clinical trial for the treatment of various fibrotic diseases, such as idiopathic pulmonary fibrosis. Bridge Biotherapeutics, Inc. has a research collaboration with Atomwise to launch small molecule programs across various therapeutic areas using structure-based AI technology for drug discovery; the University of Colorado School of Medicine to explore the potential of BBT-877 for immuno-oncology; and the Emory University School of Medicine to explore combination therapy of BBT-877 for KRAS/P53 mutant NSCLC patients resistant to anti-PD-1 blockade. The company was formerly known as Bridge Biotherapeutics, Inc. and changed its name to Parataxis Korea, Inc. in August 2025. The company was founded in 2015 and is headquartered in Seongnam-si, South Korea.

Sector Financial Services
Industry Capital Markets
Sub-Industry Coal & Consumable Fuels
Employees 21
Exchange KQ
Fiscal Year End December
Website Visit Website

Stock Returns

Share Price $416.00
1W Return -3.93%
1M Return -44.16%
3M Return -53.31%
1Y Return -93.16%
1Y vs BTC -59.3%
52W High $9280.00
% Down from 52W High -95.5%

Key Executives

Mr. Jun-Ho Kim CEO & Director
Age: 35
Mr. Jeong-Gyu Lee Inside Director & Head of Bio Business Division
Age: 58
Mr. Jong-Jin Lim Ph.D. VP & Head of Corporate Strategy
Age: 2026
Mr. Yong-Hee Lee Ph.D. Senior VP of Clinical Development & Head of Development
Age: 50

Company Details

Address C?s Tower, Seongnam-si, South Korea, 13486
Phone 82 31 8092 3282
Currency KRW
Most Recent Quarter 2025-12-31

Growth Metrics

Earnings Growth (YoY) 0%
Revenue Growth (YoY) -100%

Balance Sheet (Q4 2025)

Total Assets $70,830,847,350
Total Liabilities $27,041,242,650
Total Equity $43,715,479,620
Cash & Equivalents $0
Total Debt $2,934,080,000
Current Assets $22,630,490,620
Current Liabilities $23,128,933,780
Long-term Debt $2,934,080,000

Additional Financials

EBITDA -$13,963,234,304
Gross Profit -$6,159,300
Revenue per Share $0.129
Diluted EPS (TTM) $0

EPS Estimates

Current Quarter $0
Current Year $0
Next Quarter $0
Next Year $0

Frequently Asked Questions

Common questions about Bridge Biotherapeutics Inc's Bitcoin holdings

How much Bitcoin does Bridge Biotherapeutics Inc hold?

Bridge Biotherapeutics Inc currently holds 200 BTC, which represents 0.001% of the total Bitcoin supply (21 million). This makes them the 85th largest public Bitcoin holder.

What is the current value of Bridge Biotherapeutics Inc's Bitcoin holdings?

As of today, Bridge Biotherapeutics Inc's Bitcoin holdings are worth approximately $15,329,208. This represents 0.0% of the company's total market value.

What is Bridge Biotherapeutics Inc's average cost basis for Bitcoin?

Bridge Biotherapeutics Inc's average cost basis for their Bitcoin purchases is $26,363,984 per Bitcoin. Their current return on investment (ROI) is -41.86%.

When did Bridge Biotherapeutics Inc last buy Bitcoin?

Bridge Biotherapeutics Inc's most recent Bitcoin purchase was Feb 06, 2026. View purchase details

What type of company is Bridge Biotherapeutics Inc?

Bridge Biotherapeutics Inc is a public company in the Financial Services sector and Capital Markets industry with approximately 21 employees .

What is Bridge Biotherapeutics Inc's market capitalization?

Bridge Biotherapeutics Inc has a market capitalization of approximately $36,442,669,056 and annual revenue of $9,000,000 .

What is Bridge Biotherapeutics Inc's mNAV?

Bridge Biotherapeutics Inc's mNAV (Market-to-Net Asset Value) is 1186.11x, comparing the company's market value to its Bitcoin holdings value. An mNAV of 1.0 means market value equals Bitcoin stash, while >1.0 indicates a premium for the company's Bitcoin strategy.

What is Bridge Biotherapeutics Inc's market cap and enterprise value?

Bridge Biotherapeutics Inc has a market capitalization of $36,442,669,056 and an enterprise value of $39,376,749,056. Enterprise value represents the total company value including debt and cash, providing a more complete valuation picture than market cap alone.

Other public Companies

Similar companies with Bitcoin treasury holdings

RSXYZ Public Company Limited

XYZ.BK

Holdings 74.97 BTC
Value $5,746,154
ROI -11.07%

Figma, Inc.

FIG

Holdings 842.6 BTC
Value $64,581,953
ROI -29.03%

BTC-B.SE

BTC-B.SE

Holdings 167.33 BTC
Value $12,825,182
ROI 422.64%

Core Scientific, Inc.

CORZ

Holdings 613 BTC
Value $46,984,023
ROI -86.34%

Block, Inc

XYZ

Holdings 8,997.89 BTC
Value $689,652,637
ROI 120.57%
Newhedge
© 2026 Newhedge. All Rights Reserved.

Chat

You are commenting as a guest. .

alon

Hey @trader, which data isn't updating? Are you talking about the website speed?

Comment from Bitcoin Dashboard

trader

Please why are the data's on newhedge taking so long to updates? I mean hours

Comment from Bitcoin Dashboard

G
Guest
radicalsound277

correct horse battery staple

Comment from Bitcoin Dashboard

G
Guest
sharputxo635

Plain brown wrapper grand forks

Comment from Bitcoin vs Gold Correlation

23 May 2026

G
Guest
radicalhardmoney456

hi

Comment from Bitcoin Dashboard

alon

:)

Comment from Bitcoin Dashboard

G
Guest
silenthodl877

Exchange reserve data! thank you

Comment from Bitcoin Exchange Reserves

G
Guest
peerlessimmutableledger591

Ship captains

Comment from Bitcoin Dashboard

maisonmargiela

Saylor and the ETFs

Comment from Bitcoin Dashboard

G
Guest
autonomousbitcoin141

who is buying?

Comment from Bitcoin Activity Rate

20 May 2026

yousifsamad07

ok

Comment from Bitcoin Total Node Distribution Map

bittynakamoto

I haven't seen a single Saylor tweet about anything defi or ethereum related

19 May 2026

G
Guest
braveselfcustody296

Michael Saylor has been reposting links to DeFi scams built on Ethereum, presumably because they are providing demand for his perpetual preferred stock STRC. As Saylor himself notes, 80% of STRC is owned by retail investors, which makes promoting these DeFi ponzis even more irre

Comment from Bitcoin Dashboard

G
Guest
braveselfcustody296

Saylor is now promoting Ship coins wowwww

Comment from Bitcoin Dashboard

drenchravine

who thinks the Hormuz Bitcoin toll will affect price?

G
Guest
anarchicseed970

apa itu devalusi rupiah

Comment from Bitcoin MVRV Ratio

G
Guest
strongpeer126

gg

Comment from Bitcoin Dashboard

18 May 2026

G
Guest
resistantuncensorable206

When a lot of people buy, the price goes up. If more people start selling than buying, the price goes down

Comment from Bitcoin Dashboard

G
Guest
strongorangepill639

How does this work

Comment from Bitcoin Reachable Node Distribution Live Map

17 May 2026

G
Guest
wildproofwork486

Good write-up. I definitely love this website. Continue the good work!